| Financial Year |
March 31 2023 |
| Monetary Funds |
526,883,219.84 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
115,193,718.98 |
| Accounts Receivable |
1,452,780,438.11 |
| Advances to Suppliers |
133,331,563.69 |
| Other Receivables |
49,188,284.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
457,283,801.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
12,041,900.84 |
| Other Current Assets |
186,143,862.91 |
| Total Current Assets |
2,966,438,974.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
504,157,826.15 |
| Investment Properties |
13,421,894.55 |
| Fixed Assetes |
734,535,776.37 |
| Under-construction Projects |
226,447,743.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
239,960,233.01 |
| R&D expenses |
-- |
| Goodwill |
206,377,820.89 |
| Long-Term Deferred and Prepaid Expenses |
4,858,680.72 |
| Deferred Income Tax Assets |
68,646,817.73 |
| Other Non-Current Assets |
29,430,501.25 |
| Sub-Total of Non-Current Assets |
2,052,828,668.98 |
| Total Assets |
5,019,267,643.00 |
| Short-Term Loans |
362,393,575.06 |
| Trading Financial liabilities |
-- |
| Notes Payable |
236,337,500.86 |
| Accounts Payable |
273,870,281.83 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,590,444.43 |
| Taxes Payable |
43,766,807.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
18,104,925.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,678,181.32 |
| Other Current Liabilities |
1,172,977.06 |
| Sub-Total of Current Liabilities |
962,087,322.20 |
| Long-term Loans |
891,510,627.77 |
| Bonds Payable |
59,045,648.97 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
27,333,500.00 |
| Deferred Income Tax Liabilities |
5,989,306.22 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,020,877,089.36 |
| Total Liabilities |
1,982,964,411.56 |
| Paid-In Capital(Or Share Stock) |
1,076,863,448.00 |
| Capital Surplus |
677,828,517.36 |
| Surplus Reserve |
108,381,237.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,102,838,357.91 |
| Minority Stockholder's Interest |
55,444,072.49 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,980,859,158.95 |
| Owner's Equity（Stockholder's Equity） |
3,036,303,231.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,019,267,643.00 |
